Literature DB >> 26354506

Kv1.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages.

Hong Zhu1, Li Yan2, JingLi Gu1, Wei Hao1, JiMin Cao3.   

Abstract

This study aimed to comprehend the largely unknown role of voltage-gated potassium channel 1.3 (Kv1.3) in the phagocytic function of macrophages. We found that blocking of the Kv1.3 channel with 100 pmol L(-1) Stichodactyla helianthus neurotoxin (ShK) enhanced the phagocytic capacities of both resting and lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages in the chicken erythrocyte system. In the fluorescein isothiocyanate (FITC)-labeled Escherichia coli k-12 system, ShK increased the phagocytic capacities of resting RAW264.7 cells, but not of the LPS-stimulated cells, as LPS alone stimulated almost saturated phagocytosis of the macrophages. ShK increased the nitric oxide (NO) production in LPS-activated cells, but not in resting RAW264.7 cells. There was no effect of ShK alone on the cytokine secretions in resting RAW264.7 cells, but it suppressed IL-1β secretion in LPS-stimulated RAW264.7 cells. At a concentration of 100 pmol L(-1), ShK did not affect the viability of the tested cells. Kv1.3 was expressed in RAW264.7 cells; this expression was downregulated by LPS, but significantly upregulated by disrupting caveolin-dependent endocytosis with filipin III. In addition, cytochalasin D, an inhibitor of actin polymerization, did not affect the Kv1.3 expression. Thus, blocking of the Kv1.3 channel enhances the phagocytic capacity and NO production of this cell line. Our results suggest that Kv1.3 channel serves as a negative regulator of phagocytosis in macrophages and can therefore be a potential target in the treatment of macrophage dysfunction.

Entities:  

Keywords:  Kv1.3 channel; immunoregulation; macrophage activation syndrome; phagocytosis

Mesh:

Substances:

Year:  2015        PMID: 26354506     DOI: 10.1007/s11427-015-4915-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  6 in total

1.  A Comparative Study of Fluoroquinolone-Resistant Escherichia coli Lineages Portrays Indistinguishable Pathogenicity- and Survivability-Associated Phenotypic Characteristics Between ST1193 and ST131.

Authors:  Jiangqing Huang; Shengcen Zhang; Shuyu Zhang; Zhichang Zhao; Yingping Cao; Min Chen; Bin Li
Journal:  Infect Drug Resist       Date:  2020-11-20       Impact factor: 4.003

2.  Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis.

Authors:  Zhenhui Deng; Qingye Zeng; Jie Tang; Bei Zhang; Jinwei Chai; John F Andersen; Xin Chen; Xueqing Xu
Journal:  J Biol Chem       Date:  2021-04-14       Impact factor: 5.157

3.  Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial-mesenchymal transition in HepG2 cells.

Authors:  Hyunkyoung Lee; Min Jung Pyo; Seong Kyeong Bae; Yunwi Heo; Indu Choudhary; Duhyeon Hwang; Hyeryeon Yang; Je-Hein Kim; Jinho Chae; Chang Hoon Han; Changkeun Kang; Seungshic Yum; Euikyung Kim
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

4.  Crotamine stimulates phagocytic activity by inducing nitric oxide and TNF-α via p38 and NFκ-B signaling in RAW 264.7 macrophages.

Authors:  Kyung Jin Lee; Yun Kyu Kim; Martin Krupa; Anh Ngoc Nguyen; Bich Hang Do; Boram Chung; Thi Thu Trang Vu; Song Cheol Kim; Han Choe
Journal:  BMB Rep       Date:  2016-03       Impact factor: 4.778

5.  Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in Monocytes.

Authors:  Shaoping Wang; Yuhua Ran; Xuejun Chen; Chungang Li; Shujuan Cheng; Jinghua Liu
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

6.  Epidemic Potential of Escherichia coli O16:H41-ST131: Compared with Pandemic O25b:H30-ST131 Lineage.

Authors:  Shengcen Zhang; Qianwen Zhang; Jiangqing Huang; Yingping Cao; Zhichang Zhao; Bin Li
Journal:  Infect Drug Resist       Date:  2021-07-08       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.